The global scoliosis management market is poised for steady growth, with projections indicating a rise from USD 2,942.8 million in 2022 to USD 4,489.0 million by 2032. This reflects a compound annual growth rate (CAGR) of 3.9% during the forecast period.
Several factors are driving the market’s expansion, including the high prevalence of scoliosis worldwide and the increasing adoption of braces as an effective treatment option. Additionally, technological advancements, such as tracking devices that monitor patients’ health in real-time, are contributing to the development of more efficient scoliosis management solutions. The rising demand for minimally-invasive therapies is also expected to boost market growth.
As healthcare providers and patients alike seek more personalized and non-invasive treatment options, the scoliosis management market is expected to see sustained growth over the next decade.
Scoliosis is a medical disorder causing deformities in spine especially sideway curvature forming S or C shape in the spinal region. Scoliosis generally occurs during the pre-puberty phase. The major cause of scoliosis is primarily due to disorders such as muscular dystrophy and cerebral palsy, and are most common causative conditions, and other cause of scoliosis is still unknown. In early cases, scoliosis is minor,
however if untreated or unresolved may lead to severe deformities. Scoliosis results in reducing space within chest cavity, thus, causes difficulties in the proper functioning of lungs. The other factors such as environmental factors and genetic factors can also cause scoliosis. In addition, scoliosis management consists of complex procedures for correcting the shape of the spine and management steps are selected based on the level of severity of the disorder and bone maturity coupled with the degree of progression of scoliosis which may differ in males and females. For scoliosis management, braces, physical therapies such as exercise, self-care, and leisure, alternative medicines, and surgeries are often used.
Global Scoliosis Management Industry : Drivers and Restraints
The scoliosis management market growth is mainly driven by the increasing prevalence of scoliosis in the global population. For instance, according to the estimates of National Scoliosis Foundation (NSF), approximately 2–3% of the population is suffering from scoliosis in U.S. alone with estimates of six to nine million people. In addition, nearly 600,000 patient visits to private facilities, more than 30,000 adolescents using braces, and approximately 38,000 patients have undergone spinal fusion surgeries. All these factors are responsible for driving the overall growth of the Global Scoliosis Management Industry . However, the factors such as high cost of treatment or procedures can impede the market growth. Moreover, other factors such as lack of skilled professionals, unfavorable reimbursement policies, and limited understanding of the disorder and available treatment options are also hampering the overall growth of Global Scoliosis Management Industry .
Global Scoliosis Management Industry : Overview
Global Scoliosis Management Industry is expected to show a tremendous growth during the forecast period. Scoliosis is mainly diagnosed by using X-ray technology and aids in the calculation of a degree of curvature. Scoliosis management is based on the degree or pattern of curvature of the spine, age, type of scoliosis, and level of progression. In early cases of scoliosis, observation is done for a time period of 4 -5 months. Scoliosis is a common medical condition of spine in adolescents and creates an ample opportunity for market participants to invest in scoliosis management owing to the fact that scoliosis has high prevalence and incidence rate in the overall population, resulting in demand for better treatment and management options.
Global Scoliosis Management Industry : Region Wise Outlook
Geographically, Global Scoliosis Management Industry can be segmented as North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan and Middle East & Africa. North America is expected to hold the largest market share followed by Western Europe owing to the factors such as the presence of more sophisticated healthcare infrastructure, increasing awareness among the population and higher prevalence. In addition, other factors such as high R&D expenditure by governmental bodies, and availability of favorable reimbursement policies in these regions boosts the overall growth of scoliosis management market.
The market in Asia-Pacific excluding Japan region is estimated to grow at fastest CAGR over the forecast period owing to increasing healthcare expenditure, and easy availability of management options. Moreover, consistent technological advancement and product launches in this region also boosts the growth of scoliosis management market. However, the regions such as Latin America and Middle East and Africa show a stagnant growth during the forecast year owing to the dearth of skilled personnel and low per capita healthcare expenditure in these regions, apart from lack of awareness about the disease.
Global Scoliosis Management Industry : Key Players
Some of the market participants in the Global Scoliosis Management Industry are Boston Orthotics & Prosthetics, Chaneco, Original Bending Brace, Orthotech, Trulife, L.A. Brace, Össur, DJO, LLC, Wilmington Orthotics & Prosthetics, Inc., Lawall Prosthetics and Orthotics, Horton’s Orthotics & Prosthetics, Aspen Medical Products, UNYQ, C H Martin Company, Optec USA, Inc., Spinal Technology, Inc., Ortholutions GmbH & Co. KG, Wellinks, Inc., and Pro-Tech Orthopedics.
Key Segments:
By Disease Type:
- Infantile Idiopathic Scoliosis
- Juvenile Idiopathic Scoliosis
- Adolescent Idiopathic Scoliosis
By Age:
- Pediatric
- Adult
By Product Type:
- Cervical Thoracic Lumbar Sacral Orthosis (CTLSO)
- Thoracolumbosacral Orthosis (TLSO)
- Lumbosacral Orthosis (LSO)
By Distribution Channels:
- Hospitals & Clinics
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Latin America
- Asia Pacific
- Middle East and Africa (MEA)
- Europe
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
